I’m Tayga Musal.
Bridging Biology & Finance.
Currently studying Molecular and Cellular Biology at Université de Strasbourg, I occupy the unique intersection of life sciences and financial markets. My work explores how deep scientific research translates into market-moving innovation.
Areas of Expertise
Biotechnology
I delve into the molecular mechanisms behind cutting-edge therapies, from CRISPR gene editing to personalized medicine, evaluating how scientific breakthroughs translate into therapeutic reality.
Venture Capital
I explore how early-stage capital supports breakthrough biotech and healthcare companies, and what that means for long-term value and impact.
Pharmaceutical Innovation
Analyzing the lifecycle of drug development, from R&D pipelines to regulatory approval, ensuring a deep understanding of how new medicines reach the market.
Healthcare Investing
My analysis focuses on market trends and financial performance within health tech and pharma, identifying the economic drivers of long-term healthcare value.
The Motivation
Turning curiosity into knowledge, and knowledge into opportunity
What started as an academic interest in biology gradually developed into a broader curiosity about the industries, companies, and ideas shaping modern healthcare. This blog is a place where I share my experiences, reflections, and observations as I continue to learn about healthcare, markets, and the forces that drive innovation.